Gut Cells and Brain Health: New Clues for MS Care Now

Credibility

Interest

Key Takeaway

Cells in the gut called enteric glial cells can both hurt and help the brain, and changing what they do might reduce MS symptoms.

What They Found

Researchers reviewed studies showing enteric glial cells (EGCs), a type of support cell in the gut, send signals to the brain and back, which can influence brain diseases. EGCs can act two ways: sometimes they calm inflammation and protect nerves, and other times they become reactive and release substances that increase inflammation. This “double-edged” behavior means the same cells might help or harm depending on what triggers them, like stress, infection, or diet. The review noted links between EGCs and many brain disorders, including multiple sclerosis (MS), suggesting gut changes may be part of how MS starts or gets worse. It also described possible treatments — such as certain drugs and food compounds (like polyphenols and compounds in Brazil nuts) — that might shift EGCs toward the helpful side.

Who Should Care and Why

People with MS and their caregivers should care because the gut may be a place to reduce inflammation that affects the brain and spinal cord — think of the gut as a support team that can either help or hurt a player on the field. If EGCs are pushed into a protective mode, that might lower nerve damage or flare-ups; if pushed the other way, they could make symptoms worse. Doctors and caregivers could consider diet and lifestyle steps that support healthy gut cells, similar to tending a garden so plants grow strong instead of letting weeds take over. Researchers and clinicians can use this idea to test new treatments that target the gut rather than the brain directly, which might mean different pills or food choices for people with MS. MS patients who have gut symptoms (like constipation, diarrhea, or belly pain) may find this especially relevant because those symptoms could be linked to processes that also affect their MS.

Important Considerations

This article is a review of many studies, not a single experiment, so it summarizes ideas and possible directions rather than proving a new treatment works. Much of the research is early, often in animals or cells, so we don’t yet know which diet changes or drugs will help people with MS for sure. Before trying new supplements or treatments mentioned, talk with your neurologist or care team because some compounds can interact with MS medicines or cause side effects.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression Living with MS

Article Topics:

enteric glial cellsenteric nervous systemgut–brain axisneurodegenerative diseases

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurochemistry often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News